2023

Abstract blue cross shape with flowing dark teal wave lines on a solid black background.
Abstract soft light blue gradient glow on a solid white background.
11 • 09 • 2023
NervGen Pharma Reports Q3 2023 Financial Results and Operational Updates
11 • 08 • 2023
Neuroscientist and NervGen Pharma Scientific Founder, Dr. Jerry Silver, Interviewed on ‘Remarkable People’ Podcast Hosted by Tech Luminary Guy Kawasaki
10 • 23 • 2023
NervGen Pharma Receives Fast Track Designation for NVG-291 for the Treatment of Individuals with Spinal Cord Injury
10 • 17 • 2023
NervGen Pharma Appoints John Ruffolo to Board of Directors
09 • 25 • 2023
NervGen Pharma Announces First Subject Dosed in Landmark Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury
09 • 11 • 2023
NervGen Pharma to Present at 2023 International Spinal Research Trust Network Meeting
09 • 05 • 2023
NervGen Pharma to Present on Its Drug Candidate NVG-291 and Spinal Cord Injury at the H.C. Wainwright 25th Annual Global Investment Conference
08 • 22 • 2023
NervGen Pharma to Present on its Drug Candidate NVG-291 and Spinal Cord Injury at Investor Conference
08 • 09 • 2023
NervGen Pharma Reports Q2 2023 Financial Results and Operational Updates
1 2 3